Publications

View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.

September 2025

Cardiovascular safety of systemic psoriasis treatments: A prospective cohort study in the BIOBADADERM registry

J Eur Acad Dermatol Venereol 2025;39:1631–42 https:// doi. org/ 10. 1111/ jdv. 20828

Lluch-Galcerá JJ,

González-Quesada A,

Sahuquillo-Torralba A,

Rivera-Díaz R,

Gómez-García FJ,

Herrera-Acosta E,

Lopez-Estebaranz JL,

Baniandrés-Rodríguez O,

Riera-Monroig J,

Ruiz-Carrascosa JC,

Abalde-Pintos MT,

Roncero-Riesco M,

García-Donoso C,

Llamas-Velasco M,

Del Alcázar E,

Suárez-Pérez JA,

Rodríguez-Sánchez B,

Díez-Madueño K,

Ruiz-Villaverde R,

Lezcano-Biosca V,

González-Sixto B,

Ángel Descalzo M,

García-Doval I

This study by Lluch-Galcerá et al. provides valuable RWE to inform personalized clinical decision-making in the treatment of PsO. Authors evaluated the incidence of MACE associated with each systemic treatment used for patients with PsO and compared these rates to those observed with MTX.

Keywords: